CAS RN: 77862-24-9
4-METHYL-3-METHYLAMINOPYRIDINE
Product Availability
Choose a grade to view its available package options.
1 package records 1 with current stock 1 grade group
Grade
97% (1)
In stock only
Batch No. Package Availability Warehouse Inquiry
Batchno.20250623
250mg / 1g / 5g
Confirm by inquiry
Shanghai Inquiry
GET A QUOTE
This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 1g
Available purity: ≥95%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 77862-24-9
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
1g
≥95%
0
Out of Stock
Shenzhen
Inquiry
77862-24-9 / (4-methyl-3-pyridinyl)methanamine
Standard CAS: 77862-24-9
Multi CAS: Yes
Basic Information
copy
CAS
77862-24-9 copy
Multi CAS
Yes copy
Molecular Formula
C7H10N2 copy
Molecular Weight
122.170000 copy
Exact Mass
122.084398 copy
InChI
InChI=1S/C7H10N2/c1-6-3-4-9-5-7(6)8-2/h3-5,8H,1-2H3 copy
InChIKey
HJDXNIYRGXNPCP-UHFFFAOYSA-N copy
Computed Properties
copy
Structural Parameters
Heavy atom count
9 copy
Aromatic heavy atom count
6 copy
Fraction Csp3
0.29 copy
Rotatable bonds
1 copy
H-bond acceptors
2 copy
H-bond donors
1 copy
Molar refractivity
36.87 copy
TPSA
38.91 copy
LogP / Solubility
WLOGP
0.85 copy
MLOGP
0.74 copy
XLogP3
0.1 copy
Consensus LogP
0.56 copy
Log S (ESOL)
-1.56 copy
Class (ESOL)
Soluble copy
Log S (Ali)
-1.17 copy
Class (Ali)
Soluble copy
Log S (SILICOS-IT)
-1.28 copy
Class (SILICOS-IT)
Soluble copy
ADME
GI absorption
High copy
BBB permeant
Yes copy
P-gp substrate
No copy
CYP1A2 inhibitor
No copy
CYP2C19 inhibitor
No copy
CYP2C9 inhibitor
No copy
CYP2D6 inhibitor
No copy
CYP3A4 inhibitor
No copy
Log Kp (skin permeation)
-2.86 copy
Drug-likeness / Medicinal Chemistry
Lipinski
Yes copy
Ghose
No copy
Veber
Yes copy
Egan
Yes copy
Muegge
No copy
Bioavailability score
0.55 copy
Leadlikeness
No copy
Synthetic Accessibility
1.5 copy